intricacy 发表于 2025-3-23 13:35:09

Submitted on: 16 July 2002.
Revised on: 30 August 2002.
Accepted on: 04 October 2002.

___________________Case Reports in Oncological Medicine

Cultivate 发表于 2025-3-23 17:12:33

Submitted on: 07 October 2017.
Revised on: 02 November 2017.
Accepted on: 05 December 2017.

___________________Case Reports in Oncological Medicine

sed-rate 发表于 2025-3-23 18:17:36

http://reply.papertrans.cn/1/49/4828/4828-13.png

prosperity 发表于 2025-3-24 01:42:15

http://reply.papertrans.cn/1/49/4828/4828-14.png

难取悦 发表于 2025-3-24 04:29:12

http://reply.papertrans.cn/1/49/4828/4828-15.png

Obloquy 发表于 2025-3-24 08:52:48

http://reply.papertrans.cn/1/49/4828/4828-16.png

橡子 发表于 2025-3-24 13:09:33

Submitted on: 23 October 2001.
Revised on: 05 December 2001.
Accepted on: 31 January 2002.

___________________Case Reports in Oncological Medicine

Parameter 发表于 2025-3-24 18:09:06

Submitted on: 14 November 2012.
Revised on: 09 December 2012.
Accepted on: 21 January 2013.

___________________Case Reports in Oncological Medicine

不满分子 发表于 2025-3-24 22:02:06

Submitted on: 21 October 1998.
Revised on: 29 January 1999.
Accepted on: 24 February 1999.

___________________Case Reports in Oncological Medicine

arrogant 发表于 2025-3-25 01:54:58

Submitted on: 03 November 2013.
Revised on: 29 November 2013.
Accepted on: 20 December 2013.

___________________Case Reports in Oncological Medicine
页: 1 [2] 3 4
查看完整版本: ESCI期刊Case Reports in Oncological Medicine 2024/2025影响因子:0.618 (CASE REP ONCOL MED) (2090-6706). (ONCOLOGY)(肿瘤学)Emergin